People | September 30, 2025
GSK names Luke Miels as next CEO
Miels will formally assume the role on January 1, 2026
Miels will formally assume the role on January 1, 2026
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
Bayer expects 2025 to be the most difficult year of its turnaround
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Subscribe To Our Newsletter & Stay Updated
